Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Paresthesia 2Hypesthesia 2Depression 2Anxiety Disorders 2

Interventions

Oxygen 2Melatonin 2Ketamine 2Ultraviolet Therapy 1Surveys and Questionnaires 1Saline Solution 1Referral and Consultation 1Psychotherapy, Group 1Mindfulness-Based Stress Reduction 1Milnacipran 1Methylphenidate 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Depression × Oxygen × Clear all
NCT06799351 2025-02-12

OzoParQTmicrob

Dr. Negrin University Hospital

Phase 2/3 Recruiting
42 enrolled

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

NCT06706544 2025-02-11

OzoParQT

Dr. Negrin University Hospital

Phase 2/3 Recruiting
42 enrolled

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡